CMIC’s Malaysia office was established in 2013 in Kuala Lumpur, Malaysia to provide full operational services in the execution of clinical trials under the Pharmaceutical Value Creator (PVC) model. With more than 5 years’ experience in the country for projects of global and local scales, we understand the country’s biopharmaceutical and healthcare markets.
Our combination of industry experience and expertise across a broad spectrum of therapeutic areas and phases can help you accelerate clinical and commercial success to deliver better medicines, sooner.
Malaysia has a large population pool of potential patients, especially for infections diseases and vaccines. With a relatively large amount of English speakers in the country, and lower costs, this country may a great entry option for you. CMIC ensures a wise selection of clinical trial qualified sites with experience and sufficient access to patient pools for your study.
Regulatory consultation and dossier submission to health authorities (HA) and ethics committees (EC)
Clinical monitoring and site management
Full Biometrics support and Clinical Study Report (CSR) writing
Pharmacovigilance and medical monitoring
Quality assurance and quality compliance services
Facility Contact Information
C-2-3A TTDI Plaza, Jalan Wan Kadir 3, Taman Tun Dr. Ismail, 60000 Kuala Lumpur
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.